Logo Image
News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsShortsTraining Academy
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEventsAdvanced Practice Corner
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

MaryBeth Freeman, MPH

Advertisement

Articles by MaryBeth Freeman, MPH

Prostate Cancer Diagnoses Decrease With Lenient Screening Recommendations

ByMaryBeth Freeman, MPH
May 8th 2019

After the USPSTF advised against prostate cancer screening for all men, there was a decrease in the incidence of the disease.

Advertisement

Latest Updated Articles

  • Prostate Cancer Diagnoses Decrease With Lenient Screening Recommendations
    Prostate Cancer Diagnoses Decrease With Lenient Screening Recommendations

    May 8th 2019



Advertisement
Advertisement

Trending on Oncology Nursing News

1

Managing GLP-1 Toxicities in Breast Cancer: Insights for Oncology Nurses

2

Geriatric Assessment Optimizes Older Patients for Bone Marrow Transplant

3

FDA Approves Palbociclib for HR+/HER2+ Metastatic Breast Cancer Maintenance

4

Skin Safety Strategies for Oncology Patients

5

FDA Approves Sacituzumab Govitecan-hziy for First-Line Triple-Negative Breast Cancer

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us